---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-003998"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:18:33.526318+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals announces 1-for-50 reverse stock split effective June 4, 2024 to meet Nasdaq minimum bid price

## Summary
- 1-for-50 reverse stock split effective 4:01 PM ET June 4, 2024; trading on split-adjusted basis from June 5, 2024 under symbol CNSP.
- Outstanding shares reduced from ~16.25M to ~325K; authorized shares remain 300M; par value unchanged at $0.001.
- No fractional shares issued; fractional shares rounded up to nearest whole share.
- Split intended to increase per share trading price to comply with Nasdaq minimum bid price listing requirement.
- Warrants and equity awards proportionally adjusted: shares underlying divided by 50, exercise price multiplied by 50.

## SEC filing metadata
- accession: 0001683168-24-003998
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824003998/0001683168-24-003998-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824003998/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-003998
- JSON: https://secwatch.observer/filing/0001683168-24-003998.json
- Plain text: https://secwatch.observer/filing/0001683168-24-003998.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.